A woman with recurrent calcium phosphate Kidney stones

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 7, 2012, Pages 1172-1178

  Goldfarb, David S ^a,b,c  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b LENOX HILL HOSPITAL   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM OXALATE; CALCIUM PHOSPHATE; CHLORTALIDONE; CITRATE POTASSIUM; CITRIC ACID; CREATININE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; PHOSPHORUS; SODIUM; URIC ACID;

ARTICLE; CALCIUM EXCRETION; CALCIUM PHOSPHATE KIDNEY STONE; CALCIUM URINE LEVEL; CREATININE URINE LEVEL; DIET THERAPY; EXERCISE; FLUID THERAPY; HUMAN; HYPERCALCIURIA; HYPOCITRATURIA; KIDNEY TUBULE ACIDOSIS; NEPHROLITHIASIS; RECURRENT DISEASE; SODIUM INTAKE; SODIUM RESTRICTION; SODIUM URINE LEVEL; URIC ACID URINE LEVEL; URINE PH;

CALCIUM PHOSPHATES; FEMALE; HUMANS; KIDNEY CALCULI; YOUNG ADULT;

EID: 84863769689     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00560112     Document Type: Article

References (32)

1. MandelNS, MandelGS: Urinary tract stone disease in the United States veteran population. II. Geographical analysis of variations in composition. J Urol 142: 1516-1521, 1989
2. Coe FL, Evan A, Worcester E: Pathophysiology-based treatment of idiopathic calcium kidney stones. Clin J Am Soc Nephrol 6: 2083-2092, 2011
3. Parks JH, Worcester EM, Coe FL, Evan AP, Lingeman JE: Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int 66: 777-785, 2004
4. Mandel N, Mandel I, Fryjoff K, Rejniak T, Mandel G: Conversion of calcium oxalate to calcium phosphate with recurrent stone episodes. J Urol 169: 2026-2029, 2003
5. Carpentier X, Daudon M, Traxer O, Jungers P, Mazouyes A, Matzen G, Véron E, BazinD: Relationships between carbonation rate of carbapatite and morphologic characteristics of calcium phosphate stones and etiology. Urology 73: 968-975, 2009
6. Krambeck AE, Lingeman JE, McAteer JA, Williams JC Jr: Analysis of mixed stones is prone to error: A study with US laboratories using micro CT for verification of sample content. Urol Res 38: 469-475, 2010
7. Welch BJ, Graybeal D, Moe OW, Maalouf NM, Sakhaee K: Biochemical and stone-risk profiles with topiramate treatment. Am J Kidney Dis 48: 555-563, 2006
8. Pak CY, Poindexter JR, Adams-Huet B, Pearle MS: Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 115: 26-32, 2003
9. Parks JH, Coward M, Coe FL: Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int 51: 894-900, 1997
10. Arampatzis S, Röpke-Rieben B, Lippuner K, Hess B: Prevalence and densitometric characteristics of incomplete distal renal tubular acidosis in men with recurrent calcium nephrolithiasis. Urol Res 40: 53-59, 2012
11. Gault MH, Chafe LL, Morgan JM, Parfrey PS, Harnett JD, Walsh EA, Prabhakaran VM, Dow D, Colpitts A: Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones. Medicine (Baltimore) 70: 345-359, 1991
12. Thorleifsson G, Holm H, Edvardsson V, Walters GB, Styrkarsdottir U, Gudbjartsson DF, Sulem P, Halldorsson BV, de Vegt F, d'Ancona FC, den Heijer M, Franzson L, Christiansen C, Alexandersen P, Rafnar T, Kristjansson K, Sigurdsson G, Kiemeney LA, Bodvarsson M, Indridason OS, Palsson R, Kong A, Thorsteinsdottir U, Stefansson K: Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet 41: 926-930, 2009
13. VezzoliG, Terranegra A, Rainone F, Arcidiacono T, CozzolinoM, Aloia A, Dogliotti E, Cusi D, Soldati L: Calcium-sensing receptor and calcium kidney stones. J Transl Med 9: 201, 2011
14. Pak CY, Britton F, Peterson R, Ward D, Northcutt C, Breslau NA, McGuire J, Sakhaee K, Bush S, Nicar M, Norman DA, Peters P: Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. Am J Med 69: 19-30, 1980
15. Asplin JR, Bauer KA, Kinder J, Müller G, Coe BJ, Parks JH, Coe FL: Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int 63: 662-669, 2003
16. Worcester EM, Coe FL: New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol 28: 120-132, 2008
17. Bergsland KJ, Coe FL, Gillen DL, Worcester EM: A test of the hypothesis that the collecting duct calcium-sensing receptor limits rise of urine calciummolarity in hypercalciuric calcium kidney stone formers. Am J Physiol Renal Physiol 297: F1017-F1023, 2009
18. Goldfarb DS: Prospects for dietary therapy of recurrent nephrolithiasis. Adv Chronic Kidney Dis 16: 21-29, 2009
19. Meschi T, Maggiore U, Fiaccadori E, Schianchi T, Bosi S, Adorni G, Ridolo E, Guerra A, Allegri F, Novarini A, Borghi L: The effect of fruits and vegetables on urinary stone risk factors. Kidney Int 66: 2402-2410, 2004
20. Dussol B, Iovanna C, Rotily M, Morange S, Leonetti F, Dupuy P, Vazi A, Saveanu A, Loundou A, Berland Y: A randomized trial of low-animal-protein or high-fiber diets for secondary prevention of calcium nephrolithiasis. Nephron Clin Pract 110: c185-c194, 2008
21. Taylor EN, Fung TT, Curhan GC: DASH-style diet associates with reduced risk for kidney stones. J AmSoc Nephrol 20: 2253-2259, 2009
22. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A: Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346: 77-84, 2002
23. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY: Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 150: 1761-1764, 1993
24. Preminger GM, Sakhaee K, Skurla C, Pak CY: Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J Urol 134: 20-23, 1985
25. Adams JS, Song CF, Kantorovich V: Rapid recovery of bone mass in hypercalciuric, osteoporotic men treated with hydrochlorothiazide. Ann Intern Med 130: 658-660, 1999
26. Pearle MS, Roehrborn CG, Pak CY: Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol 13: 679-685, 1999
27. Bushinsky DA, Asplin JR: Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats. J Am Soc Nephrol 16: 417-424, 2005
28. Huen SC, Goldfarb DS: Adverse metabolic side effects of thiazides: Implications for patients with calcium nephrolithiasis. J Urol 177: 1238-1243, 2007
29. Borghi L, Meschi T, Guerra A, Novarini A: Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol 22[Suppl 6]: S78-S86, 1993
30. Asplin JR, Donahue SE, Lindeman C, Michalenka A, Strutz KL, Bushinsky DA: Thiosulfate reduces calcium phosphate nephrolithiasis. J Am Soc Nephrol 20: 1246-1253, 2009
31. Saigal CS, Joyce G, Timilsina AR; Urologic Diseases in America Project: Direct and indirect costs of nephrolithiasis in an employed population: Opportunity for disease management? Kidney Int 68: 1808-1814, 2005
32. Leaf DE, Korets R, Taylor EN, Tang J, Asplin JR, Goldfarb DS, Gupta M, Curhan GC: Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers. Clin J Am Soc Nephrol 7: 829-834, 2012